Jeffrey S. Hatfield
CIK: 0001609879
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VIR
Vir Biotechnology, Inc.
Director
Discretionary Trading P&L
Holdings
About Hatfield Jeffrey S.
Hatfield Jeffrey S. (SEC CIK 0001609879) files insider reports with the SEC as Director of Vir Biotechnology, Inc. (VIR).
Signal8 holds 2 ownership filings by Hatfield Jeffrey S., all Form 4s, filed between Jun 2, 2025 and May 28, 2026. Those filings report 2 transactions, from May 30, 2025 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hatfield Jeffrey S.'s filings is in SAN FRANCISCO, CA.
Recent filings by Hatfield Jeffrey S.
Other insiders filing for Vir Biotechnology, Inc. (VIR)
- Topalian Suzanne Louise, Director
- Sawaf Aziz, EVP, Chief Financial Officer
- MORE ROBERT J, Director
- Coughlin Timothy, Director
- Napolitano Janet, Director
- Sabatini Brent, SVP, Chief Accounting Officer